First Allied Advisory Services’s Purple Biotech PPBT Stock Holding History

First Allied Advisory Services’s Portfolio PPBT Stock Details PPBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8	Closed	-$46K	–	1089
2016 Q2	$46K	Buy	+8	New	+$80.1K	﹤0.01%	1019

Other funds holding PPBT

Menta Capital San Francisco, California $236M AUM 6.6% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

FMA

FNY Managed Accounts New York $83.4M AUM 11.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

First Allied Advisory Services's PPBT Position: Q3 2016 in Review

First Allied Advisory Services sold out of Purple Biotech (PPBT) in Q3 2016, closing a stake of 8 shares — an estimated $46K sold.

First Allied Advisory Services first reported a position in PPBT in Q2 2016 and held it in 1 quarter. The position peaked at $46K in Q2 2016. 8 funds tracked by Wall St. Rank hold PPBT as of Q3 2016.

First Allied Advisory Services reported no remaining Purple Biotech position as of Q3 2016 after selling out during the quarter.
First Allied Advisory Services sold 8 Purple Biotech shares in Q3 2016, an estimated $46K.
First Allied Advisory Services first reported a position in Purple Biotech in Q2 2016 and held it in 1 quarter.
First Allied Advisory Services's Purple Biotech position peaked at $46K in Q2 2016.
8 funds tracked by Wall St. Rank held Purple Biotech as of Q3 2016.

Based on First Allied Advisory Services's 13F filing for Q3 2016, filed 14 Nov 2016.